Header Logo

Connection

COYA TAPIA to Administration, Intravenous

Back to Details
This is a "connection" page, showing publications COYA TAPIA has written about Administration, Intravenous.
COYA TAPIA
Connection Strength
0.039
Administration, Intravenous
  1. Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma. J Immunother Cancer. 2019 09 18; 7(1):253.
    View in: PubMed
    Score: 0.039
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.